Phospho-NF-κB p65 (Ser468) Antibody [G12A6]

N° de catalogue F3499

Imprimer

Description biologique

Spécificité

Phospho-NF-κB p65 (Ser468) Antibody [G12A6] reconnaît les niveaux endogènes de la protéine NF-κB p65 totale uniquement lorsqu'elle est phosphorylée au niveau de Ser468.

Contexte La Phospho-NF-κB p65 (Ser468) fait référence à la phosphorylation de la sous-unité p65 (RelA) de la famille NF-κB au niveau de la sérine 468 dans son domaine de transactivation C-terminal. La famille NF-κB régule les gènes impliqués dans l'immunité, l'inflammation et la survie cellulaire via des complexes de facteurs de transcription dimériques. p65 contient un domaine d'homologie Rel responsable de la liaison à l'ADN et de la dimérisation, et un domaine de transactivation qui médie l'activation transcriptionnelle. La phosphorylation au niveau de Ser468 est médiatisée par IKKε lors de la co-stimulation des lymphocytes T et par GSK-3β dans des conditions basales. Cette modification post-traductionnelle favorise la liaison de p65 au complexe ubiquitine ligase COMMD1–Cullin2, conduisant à l'ubiquitination et à la dégradation protéasomale de p65 lié à la chromatine. La phosphorylation au niveau de Ser468 termine sélectivement la transcription de NF-κB target genes spécifiques, tels que ICAM1, en facilitant l'élimination de p65 de la chromatine. La mutation de Ser468 altère ce mécanisme régulateur, stabilisant p65 et prolongeant son activité transcriptionnelle. La phosphorylation médiatisée par GSK-3β supprime la signalisation NF-κB basale, tandis que la phosphorylation induite par IKKε affine les réponses aux stimuli immunitaires. Cette modification sert ainsi de point d'intégration pour les signaux régulateurs constitutifs et inductibles, permettant un contrôle précis de l'activité NF-κB. La dérégulation de la phosphorylation de Ser468 est associée à l'inflammation chronique, l'auto-immunité et la tumorigénèse.

Informations dutilisation

Application WB, FCM, ELISA Dilution
WB
1:2000-1:10000
Réactivité Human, Mouse
Source Rabbit Monoclonal Antibody MW 65 kDa
Tampon de stockage PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Stockage
(À partir de la date de réception)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:2000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Références

  • https://pubmed.ncbi.nlm.nih.gov/19270718/
  • https://pubmed.ncbi.nlm.nih.gov/15465828/

Données dapplication

WB

Validé par Selleck

  • F3499-wb
    Lane 1: Hela, Lane 2: Hela (Calyculin A, 100nM, 30 min)